Asian Breast Implants Market

Cosmetic surgery segment to remain the dominant application segment in the Asian breast implants market

Cosmetic surgery segment is expected to account for more than 75% revenue share of the Asian breast implants market by 2017 end and is expected to gain more than 150 BPS in its market share over the forecast period. The cosmetic surgery segment is slated to register a CAGR of 7.4% while the reconstructive surgery segment is expected to grow at a CAGR of 6.3% over the projected period.

The reconstructive surgery segment is estimated to lose more than 150 BPS in its market share over the forecast period and reach a market valuation of more than US$ 60 Mn by 2025.

The cosmetic surgery segment is expected to dominate the Asian breast implants market in revenue terms in 2017 and this trend is projected to continue to do so throughout the forecast period. Cosmetic surgery is the most attractive application segment, recording a market attractiveness index of 1.6 over the forecast period.

The reconstructive surgery segment is likely to be the second most lucrative segment in the Asian breast implants market, with a market attractiveness index of 0.4 during the forecast period.

Rising disposable income in Asia and increasing number of women in the Asian workforce is expected to propel the growth in demand for breast implants during the projected period

Reconstructive breast surgery is usually performed in order to treat structures of the body affected functionally. Breast reconstruction after mastectomy is generally covered under Medicare resulting in the rise in a number of breast reconstruction procedures worldwide.

The rise in annual disposable income per capita of women in Asian countries is creating a positive impact on the cosmetic surgery segment of the Asian breast implants market. Socio-economic status is a prime factor creating higher demand for breast implants in Asian women. The primary customer base for breast implant procedures are women belonging to middle and high-income families.

Additionally, a significant rise in the world’s middle-class population over the next few years, resulting in an increase in purchasing power and discretionary spending are indicative of the stability and growth of the cosmetic surgery segment worldwide. Breast cancer is a leading cause of mortality worldwide particularly in less developed countries, mainly attributed to shifting lifestyles and unavailability of adequate healthcare infrastructure coupled with less penetration of clinical advancements to combat the disease. Rising prevalence of breast cancer is a major factor contributing to the revenue growth of the cosmetic and reconstructive surgery segments across the globe.

A large number of women are conscious about the physical appearance of their breasts leading to increasing number of breast augmentation procedures in developed countries such as China and Indonesia. However, some of the most common reasons for breast augmentation procedures include changing the breast size, restoring the natural appearance of the breasts, and correcting capsular contracture. This factor is likely to create robust development in the cosmetic surgery segment over the projected period.

Increasing preference for breast augmentation procedure likely to drive patients to undergo reconstructive surgeries in Rest of Asia

Growing focus on aesthetic appearance driven by popular media influences such as television shows and various consumer awareness programs is expected to drive the market for the cosmetic surgery application segment in China; while in Malaysia, fat transfer breast augmentation procedure is anticipated to fuel the cosmetic surgery application segment in the coming years.

In Indonesia, the reconstructive surgery segment is expected to reach more than US$ 3 Mn in 2017. Cheaper cost of breast implant surgery in Thailand is predicted to boost the revenue growth of the cosmetic surgery segment over the forecast period.

Market Segmentation

To know more about delivery timeline for this report Contact Sales